Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor
- 15 April 2009
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (8), 2179-2185
- https://doi.org/10.1016/j.bmcl.2009.02.111
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profilesJournal of Thrombosis and Haemostasis, 2008
- Structure–activity relationships of anthranilamide-based factor Xa inhibitors containing piperidinone and pyridinone P4 moietiesBioorganic & Medicinal Chemistry Letters, 2008
- Thiophene-Anthranilamides as Highly Potent and Orally Available Factor Xa InhibitorsJournal of Medicinal Chemistry, 2007
- Inhibitory effect of carboxylic acid group on hERG bindingBioorganic & Medicinal Chemistry Letters, 2006
- N,N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- Inhibition of Purified Factor Xa Amidolytic Activity May Not Be Predictive of Inhibition of In Vivo ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Inhibition of Factor Xa by a Peptidyl-α-ketothiazole Involves Two Steps. Evidence for a Stabilizing Conformational ChangeBiochemistry, 1999
- Development and validation of a genetic algorithm for flexible dockingJournal of Molecular Biology, 1997
- COFACTOR PROTEINS IN THE ASSEMBLY AND EXPRESSION OF BLOOD CLOTTING ENZYME COMPLEXESAnnual Review of Biochemistry, 1988